May is honored as National Cancer Research Month by the American Association for Cancer Research to acknowledge innovative and progressive research in the cancer field.
Hollings Cancer Center at MUSC is a renowned cancer research center in the U.S. As South Carolina's only National Cancer Institute (NCI)-designated cancer center, it is one of fewer than 70 NCI centers nationally.
With more than $43 million in research funding and 120 nationally recognized scientists, Hollings Cancer Center provides an environment and infrastructure that facilitates robust research focused on novel approaches to eradicating cancer.
Hollings Cancer Center has well over 300 active clinical trials, about 200 of which are enrolling patients. Clinical trials are research studies that involve people. Each study tries to answer scientific questions and seeks to identify better ways to prevent, diagnose or treat cancer. Clinical trials have guidelines for who can participate, and each trial is unique with its own set of criteria. Generally, participants are alike in key ways, such as the type and stage of cancer, age, gender or other factors.
For a list of clinical trials at MUSC and more information on common patient questions associated with clinical trial participation, click here.